Three directors join Cobra board
This article was originally published in Scrip
Executive Summary
Cobra Biologics, a manufacturer of biologics and pharmaceuticals, has appointed three non-executive directors to its board: Elisabeth Lindner, chair and CEO of Biosource Europe and a board member of BioInvent International, KaroBio and Pharmalink; Professor Carl Sundberg, a licensed physician and associate professor at the department of physiology & pharmacology at Karolinska Institute in Stockholm, Sweden, and co-founder of the Karolinska Investment Fund; and Jinyue Wang, founder and managing partner of 3N Partners (an investment partnership focused on life science/clean-tech investment), and a specialist M&A advisor to the pharmaceutical sector.